En
  • COVID Longhaulers
  • Nexavir’s benefits to CFS cases
Nexco Pharma
  • Home
  • About Us
    • History
    • Nexco Cream
    • Credential / Certificates
    • Testimonials
    • Advisory Board
  • Products
    • Nexcream
    • Nexavir Injectable
  • Publications
  • Research/ Uses
  • Contact Us
  • Home
  • About Us
    • History
    • Nexco Cream
    • Credential / Certificates
    • Testimonials
    • Advisory Board
  • Products
    • Nexcream
    • Nexavir Injectable
  • Publications
  • Research/ Uses
  • Contact Us
  • COVID Longhaulers
  • Nexavir’s benefits to CFS cases

Login

Don't have an account? Create one.

Forget Password Click Now.

Forget Password

Don't have an account? Create one.

License & Certification

  1. Home
  2. License & Certification
  • Covid Longhaulers
  • License & Certification
  • Nexavir’s benefits to CFS cases
Bio Mer FDA Certificate NSS Pwder Manufacturer 2015
Click to view
Dr. Komaroff nexavir letter
Click to view
Dr. Hermann nexavir letter
Click to view
Radpharm From Bio Mer Nexavir Import Permit
Click to view
Radpharm Nexavir Regulatory Letter US FDA May 2008
Click to view
Radpharm TGA Licence 15-03-07 & GMP For Fill And Finish
Click to view
Bio Mer GMP002 License
Click to view
Radpharm Export License Nexavir TGA
Click to view
Bio Mer Freedom From Specified Animal Diseases MAF Biosecurity Letter
Click to view
Bio Mer FDA Registration Of Drug Establishment Form
Click to view
Nexavir package insert
Click to view
Nexco cream 75 label - 15ml
Click to view
Nexco cream 75 label - 20ml
Click to view
Nexco cream 75 label - 30ml
Click to view
Contact

772 229 2992

nexco@nexco-pharma.com

Head Office

10072 S. Ocean Dr. Suite 7N
Jensen Beach, Florida
34957-2556 USA

India Office

DLF Tower, A-205, Jasola Vihar,
New Delhi - 110025, India

83969 88888

Nexco Pharma
  • Blogs
  • History
  • Advisory Board
  • Terms & Conditions
  • Sitemap

© 2017 - 2025 Nexco Pharma

Designed & Developed By ECIS